推荐文章(文章为近两年的文章,共4121篇;总点击量为:94602)
  • Haowei Yang; Jiawei Li; Zitian Wang; Davit Khutsishvili; Jiyuan Tang; Yu Zhu; Yongde Cai; Xiaoyong Dai; Shaohua Ma
    Life medicine 2024年第3卷第2期 DOI:10.1093/LIFEMEDI/LNAE016
    关键词: organoid;organoid micropatterning;organoid standardization;organoids-on-a-chip
    摘要: Synthetic organ models such as organoids and organ-on-a-chip have been receiving recognition from administrative agencies. Despite the proven success of organoids in predicting drug efficacy on laboratory scales, their translational advances have not fully satisfied the expectations for both clinical implementation and commercial applications. The transition from laboratory settings to clinical applications continues to encounter challenges. Employing engineering methodologies to facilitate the bridging of this gap for organoids represents one of the key directions for future advancement. The main measures to bridge the gap include environmental and phenotypic recapitulation, 3D patterning, matrix engineering, and multi-modality information acquisition and processing. Pilot whole-process clinical/pharmaceutical applications with fast and standardized organoid models will continuously offer convincing frontline optimization clues and driving forces to the organoid community, which is a promising path to translational organoid technologies.

  • Yu Yang; Haimei Wen; Yuxin Li; Xin Zeng; Gang Wei; Zhenglong Gu; Ting Ni
    Life medicine 2024年第3卷第2期 DOI:10.1093/LIFEMEDI/LNAE021
    关键词: NDUFV3;PTBP1;cellular senescence;exon skipping;mitochondria
    摘要: As the most prevalent type of alternative splicing in animal cells, exon skipping plays an important role in expanding the diversity of transcriptome and proteome, thereby participating in the regulation of diverse physiological and pathological processes such as development, aging, and cancer. Cellular senescence serving as an anti-cancer mechanism could also contribute to individual aging. Although the dynamic changes of exon skipping during cellular senescence were revealed, its biological consequence and upstream regulator remain poorly understood. Here, by using human foreskin fibroblasts (HFF) replicative senescence as a model, we discovered that splicing factor PTBP1 was an important contributor for global exon skipping events during senescence. Down-regulated expression of PTBP1 induced senescence-associated phenotypes and related mitochondrial functional changes. Mechanistically, PTBP1 binds to the third exon of mitochondrial complex I subunit coding gene NDUFV3 and protects the exon from skipping. We further confirmed that exon skipping of NDUFV3 correlates with and partially contributes to cellular senescence and related mitochondrial functional changes upon PTBP1 knockdown. Together, we revealed for the first time that mitochondrial-related gene NDUFV3 is a new downstream target for PTBP1-regulated exon skipping to mediate cellular senescence and mitochondrial functional changes.

  • Qi Chen; Pan Deng Shi; Cheng Feng Qin
    Life medicine 2024年第3卷第2期 DOI:10.1093/LIFEMEDI/LNAE002
    关键词:
    摘要:

  • Qingyuan Liu; Ting Guo; An Yan; Kehkooi Kee
    Life medicine 2024年第3卷第2期 DOI:10.1093/LIFEMEDI/LNAE007
    关键词:
    摘要:

  • Xinyi Wang; Zhiyuan Liu; Ling Zhang; Guangyu Hu; Ling Tao; Fuyang Zhang
    Life medicine 2024年第3卷第2期 DOI:10.1093/LIFEMEDI/LNAE017
    关键词: cardiac diseases;heart;mitochondria;mitochondrial transplantation;noncardiac diseases
    摘要: Mitochondrial transplantation (MT) is a promising therapeutic strategy that involves introducing healthy mitochondria into damaged tissues to restore cellular function. This approach has shown promise in treating cardiac diseases, such as ischemia-reperfusion injury, myocardial infarction, and heart failure, where mitochondrial dysfunction plays a crucial role. Transplanting healthy mitochondria into affected cardiac tissue has resulted in improved cardiac function, reduced infract size, and enhanced cell survival in preclinical studies. Beyond cardiac applications, MT is also being explored for its potential to address various noncardiac diseases, including stroke, infertility, and genetic mitochondrial disorders. Ongoing research focused on refining techniques for mitochondrial isolation, preservation, and targeted delivery is bolstering the prospects of MT as a clinical therapy. As the scientific community gains a deeper understanding of mitochondrial dynamics and pathology, the development of MT as a clinical therapy holds significant promise. This review provides an overview of recent research on MT and discusses the methodologies involved, including sources, isolation, delivery, internalization, and distribution of mitochondria. Additionally, it explores the effects of MT and potential mechanisms in cardiac diseases, as well as non-cardiac diseases. Future prospects for MT are also discussed.

  • Chunyuan Yang; Yan Jin; Yuxin Yin
    Life medicine 2024年第3卷第2期 DOI:10.1093/LIFEMEDI/LNAE015
    关键词: assay for transposase-accessible chromatin;single-cell chromatin accessibility sequencing;single-cell multi-omics;single-cell transcriptome sequencing (scRNA-seq);tumor microenvironment
    摘要: The advent of single-cell sequencing techniques has not only revolutionized the investigation of biological processes but also significantly contributed to unraveling cellular heterogeneity at unprecedented levels. Among the various methods, single-cell transcriptome sequencing stands out as the best established, and has been employed in exploring many physiological and pathological activities. The recently developed single-cell epigenetic sequencing techniques, especially chromatin accessibility sequencing, have further deepened our understanding of gene regulatory networks. In this review, we summarize the recent breakthroughs in single-cell transcriptome and chromatin accessibility sequencing methodologies. Additionally, we describe current bioinformatic strategies to integrate data obtained through these single-cell sequencing methods and highlight the application of this analysis strategy on a deeper understanding of tumorigenesis and tumor progression. Finally, we also discuss the challenges and anticipated developments in this field.

  • Yu Chen; Xiaoyu Xu; Zhixi Chen; Lingjiang Chen; Ying Jiang; Zhiyong Mao
    Life medicine 2024年第3卷第2期 DOI:10.1093/LIFEMEDI/LNAE006
    关键词:
    摘要:

  • Yu Liu; Hongbei Mu; Yu Chen; Kexin Li; Qiaojuan Mei; Lingjuan Wang; Tianyu Tang; Qiuzi Shen; Huaibiao Li; Ling Zhang; Jing Li; Wenpei Xiang
    Life medicine 2024年第3卷第1期 DOI:10.1093/LIFEMEDI/LNAE013
    关键词: exosome;follicular fluid;granulosa cells;miRNAs;ovarian aging
    摘要: Ovarian aging is mainly characterized by a progressive decline in oocyte quantity and quality, which ultimately leads to female infertility. Various therapies have been established to cope with ovarian aging, among which exosome-based therapy is considered a promising strategy that can benefit ovarian functions via multiple pathways. Here, we isolated and characterized exosomes derived from ovarian follicular fluid and profiled the differential expression patterns of noncoding exosomal RNAs in young and aged women. Treatment with young mouse-derived exosomes efficiently rescued ovarian function in aged mice. The follicular fluid exosomes from young mice and miR-320-3p can also promote the proliferation of ovarian granulosa cells and improve mitochondrial function from old mice in vitro. The mechanism may be involve that exosomes transfer miR-320-3p to granulosa cells, and inhibit the expression of FOXQ1. Exosomes also can increase the number of primordial and growing follicles, and improve the developmental ability of oocytes in the old mice in vivo. And hnRNPA2B1 controls miR-320-3p entry into exosomes. This work provides insights into the antiaging potential of follicular fluid-derived exosomes and the underlying molecular mechanisms, which may facilitate prevention of ovarian aging and an improvement in female fertility.

  • Hao Kun Xu; Jie Xi Liu; Ze Kai Zhou; Chen Xi Zheng; Bing Dong Sui; Yuan Yuan; Liang Kong; Yan Jin; Ji Chen
    Life medicine 2024年第3卷第1期 DOI:10.1093/LIFEMEDI/LNAE009
    关键词: extracellular vesicles;osteoporosis;psychological stress;sympathetic nervous system;type H vessels
    摘要: Psychological stress has been associated with the onset of several diseases, including osteoporosis. However, the underlying pathogenic mechanism remains unknown, and effective therapeutic strategies are still unavailable. Growing evidence suggests that the sympathetic nervous system regulates bone homeostasis and vascular function under psychological stress, as well as the coupling of osteogenesis and angiogenesis in bone development, remodeling, and regeneration. Furthermore, extracellular vesicles (EVs), particularly mesenchymal stem cell extracellular vesicles (MSC-EVs), have emerged as prospecting therapies for stimulating angiogenesis and bone regeneration. We summarize the role of sympathetic regulation in bone homeostasis and vascular function in response to psychological stress and emphasize the relationship between vessels and bone. Finally, we suggest using MSC-EVs as a promising therapeutic method for treating osteoporosis in psychological stress.

  • Xudong Yao; Xiaojun Xia; David C Hay; Mike Shipston; Hongwei Ouyang
    Life medicine 2024年第3卷第1期 DOI:10.1093/LIFEMEDI/LNAE008
    关键词:
    摘要: